WuXi Biologics announced on the Hong Kong Stock Exchange that on June 14, the company's board of directors was informed by one of the company's major shareholders that it had entered into a block transaction agreement with Morgan Stanley International plc, pursuant to which the placing agent has agreed to place 82.94 million existing shares of the company held by Biologics Holdings (equivalent to approximately 2.04% of the total issued share capital of the Company as of the date of this announcement) to parties independent of and not related to the Company at a price of HK$26.6 per share.